PharmaCyte Biotech, Inc. PMCB 深 滬
已收盤 12-12 16:00:00 美东时间
1.02
0.000
0.00%
華盛通- 最 高1.02
- 今 開1.00
- 成交量 70.06万股
- 最 低 0.9367
- 昨 收 1.02
- 總市值 693.17万
- 52周最高 1.90
- 市盈率 靜 0.32
- 換手率 0.01%
- 52周最低 0.63
- 委 比 -99.85%
- 總股本 679.58万
- 歷史最高 9.98
- 量 比 0.12
- 振 幅 8.17%
- 歷史最低 0.63
- 每 手 1
- 風險率 0.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多PharmaCyte Biotech Receives Noncompliance Notice From Nasdaq; Has Until June 2026 To Regain Compliance
On December 1, 2025, PharmaCyte Biotech, Inc. (the "Company") received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") indicating that the
12-06 06:10
PharmaCyte Biotech Monetizes Femasys Stake; Cash And Securities Expected At ~$20M After Monetization, Up From $13.3M
PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company"), today announced the successful monetization of its stake in Femasys Inc. (NASDAQ:FEMY), further validating the Company's strategic approach to
11-25 22:19
PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly losses of $(1.23) per share. This is a 164.74 percent decrease over earnings of $1.90 per share from the same period last year.
09-16 05:01
PharmaCyte Biotech Invests Additional $3M In TNF Pharmaceuticals To Support LightSolver Partnership
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure TechnologiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB)
09-02 21:22
PharmaCyte Biotech Secures $7 Million Private Placement
PharmaCyte Biotech ( ($PMCB) ) has issued an update. On August 17, 2025, Pharma...
08-18 21:48
PharmaCyte Biotech Q4 EPS $1.54 Up From $(0.33) YoY
PharmaCyte Biotech (NASDAQ:PMCB) reported quarterly earnings of $1.54 per share. This is a 566.67 percent increase over losses of $(0.33) per share from the same period last year.
08-11 21:44
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers AEON Biopharma (AMEX:AEON) stock moved upwards by 10.9% to $0.67 durin...
05-28 05:06
PharmaCyte Biotech announces $7 million strategic investment in MYMD
PharmaCyte Biotech (NASDAQ:PMCB) announced a $7 million investment in MyMD Pharmaceuticals (NASDAQ:MYMD), a clinical stage biopharmaceutical company committed to developing novel therapies for age-rel...
2024-05-21 21:16
PharmaCyte Biotech Acquires $5M Stake In Emerging Women's Health Innovator Femasys, Inc.
New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has made
2023-11-15 21:34
Femasys 通过 PharmaCyte Biotech 领投的投资者战略投资获得 685 万美元额外融资
Femasys Secures $6.85M Additional Financing With Strategic Investment From Inve...
2023-11-15 08:32
